Product

Company

NCT00679224·112 sites·ClinicalTrials.gov

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

GlaxoSmithKline

The purpose of the programme is to collect safety data on ambrisentan when used in clinical practice

Age

Any age

Sex

ALL

Healthy volunteers

Not accepted

subjects who have been prescribed ambrisentan for a medically appropriate use (see approved product label)

The record

StatusCompleted

PhaseNo phase

Taking part800

StartedJun 2008

UpdatedMar 23, 2017

Conditions

Where112

Clareo Health | An Observational Study For Ambrisentan